Pradžia › Pučio takų vėžys › New York
Pučio takų vėžys klinikiniai tyrimai New York
15 tyrimai dėl Pučio takų vėžys ieško dalyvių vietose New York.
Miestai New York
Oficialus tyrimo tekstas (anglų kalba)
AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
- Research Site, Commack
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-30 · NCT06219941A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer
- Rosewell Park Comprehensive Cancer Center (Site 114), Buffalo
- Memorial Sloan Kettering Cancer Center (Site 108), New York
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-29 · NCT07265674A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)
- Research Site, Mineola
- Research Site, New York
- Research Site, New York
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-28 · NCT07221253A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)
- Perlmutter Cancer Center at NYU Langone Hospital - Long Island ( Site 0327), Mineola
- Laura and Isaac Perlmutter Cancer Center at NYU Langone ( Site 0324), New York
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT06428409Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
- Research Site, Commack
Renkami dalyviai2 fazė
Amžius nuo 18 iki 130 · Visoms lytims · Atnaujinta 2026-09-23 · NCT05489211Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer
- Memorial Sloan Kettering Cancer Centers, New York
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-14 · NCT06282575Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
- NYU Langone Hospital - Long Island Investigational Pharmacy, Mineola
- Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-10 · NCT06293898AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
- Avenzo Therapeutics Recruiting Site, New York
Renkami dalyviai1/2 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-09-04 · NCT07038343A Phase 1 Study of LNCB74 in Advanced Solid Tumors
- Roswell Park Comprehensive Cancer Center, Buffalo
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-21 · NCT06774963Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer
- Research Site, White Plains
Renkami dalyviai3 fazė
Amžius nuo 18 iki 99 · Visoms lytims · Atnaujinta 2026-08-19 · NCT06467357A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- NYU Langone Health, New York
- Icahn School of Medicine At Mount Sinai Prime, New York
- Clinical Research Alliance, Inc, Westbury
- ir dar 1
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-05 · NCT06330064A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Columbia University Irving Medical Center, New York
- Memorial Sloan Kettering Cancer Center, New York
Renkami dalyviai2 fazė
Amžius 8 ir vyresni · Visoms lytims · Atnaujinta 2026-07-27 · NCT05503797A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies
- Memorial Sloan Kettering Cancer Center, New York
Renkami dalyviai1 fazė
Amžius 16 ir vyresni · Visoms lytims · Atnaujinta 2026-06-02 · NCT07197554Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC
- Roswell Park Comprehensive Cancer Center, Buffalo
- Montefiore Medical CenterMontefiore Medical Park, The Bronx
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-04-02 · NCT05733598Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors
- NYU Langone, New York
- Memorial Sloan Kettering Cancer Center, New York
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-03-05 · NCT04900818Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.